A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEthShow others and affiliations
2024 (English)In: npj Digital Medicine, E-ISSN 2398-6352, Vol. 7, no 1, article id 112Article in journal (Refereed) Published
Abstract [en]
Alcohol consumption is associated with a wide variety of preventable health complications and is a major risk factor for all-cause mortality in the age group 15-47 years. To reduce dangerous drinking behavior, eHealth applications have shown promise. A particularly interesting potential lies in the combination of eHealth apps with mathematical models. However, existing mathematical models do not consider real-life situations, such as combined intake of meals and beverages, and do not connect drinking to clinical markers, such as phosphatidylethanol (PEth). Herein, we present such a model which can simulate real-life situations and connect drinking to long-term markers. The new model can accurately describe both estimation data according to a χ2 -test (187.0 < Tχ2 = 226.4) and independent validation data (70.8 < Tχ2 = 93.5). The model can also be personalized using anthropometric data from a specific individual and can thus be used as a physiologically-based digital twin. This twin is also able to connect short-term consumption of alcohol to the long-term dynamics of PEth levels in the blood, a clinical biomarker of alcohol consumption. Here we illustrate how connecting short-term consumption to long-term markers allows for a new way to determine patient alcohol consumption from measured PEth levels. An additional use case of the twin could include the combined evaluation of patient-reported AUDIT forms and measured PEth levels. Finally, we integrated the new model into an eHealth application, which could help guide individual users or clinicians to help reduce dangerous drinking.
Place, publisher, year, edition, pages
Springer Nature, 2024. Vol. 7, no 1, article id 112
National Category
Drug Abuse and Addiction
Identifiers
URN: urn:nbn:se:oru:diva-113568DOI: 10.1038/s41746-024-01089-6ISI: 001214185200002PubMedID: 38702474Scopus ID: 2-s2.0-85192106051OAI: oai:DiVA.org:oru-113568DiVA, id: diva2:1856953
Funder
Linköpings universitetRegion ÖstergötlandKnut and Alice Wallenberg Foundation, 2020.0182Swedish Society of MedicineSwedish Research Council, 2018-05418; 2018-03319Swedish Foundation for Strategic Research, ITM17-0245ELLIIT - The Linköping‐Lund Initiative on IT and Mobile Communications, 2020-A12Vinnova, 2020-04711EU, Horizon Europe, 101080875Knowledge Foundation, 20200017
Note
The computations were enabled by resources provided by the National Supercomputer Centre (NSC), funded by Linköping University. The authors acknowledge financial support from: ALF Grants, Region Östergötland (P.N., M.E.), Knut and Alice Wallenberg Foundation and Wallenberg Center for Molecular Medicine, Linköping University (P.N.), The Swedish Society of Medicine (PN), Bengt Ihre Foundation (PN), Magtarmfonden, Sweden (PN). GC acknowledges support from the Swedish Research Council (2018-05418, 2018-03319), CENIIT (15.09), the Swedish Foundation for Strategic Research (ITM17-0245), SciLifeLab National COVID-19 Research Program financed by the Knut and Alice Wallenberg Foundation (2020.0182), the H2020 project PRECISE4Q (777107), the Swedish Fund for Research without Animal Experiments (F2019-0010), ELLIIT (2020-A12), VINNOVA (Visual Sweden, 2020-04711), and the Horizon Europe project STRATIF-AI (101080875). GC and WL acknowledge scientific support from the Exploring Inflammation in Health and Disease (X-HiDE) Consortium, whichis a strategic research profile at Örebro University funded by the Knowledge Foundation (20200017). WL acknowledges support from the Area of Strengthe-Health at Linköping University and Region Östergötland.
2024-05-082024-05-082025-02-11Bibliographically approved